BOEBZI Trademark

Trademark Overview

On Tuesday, January 6, 2015, a trademark application was filed for BOEBZI with the United States Patent and Trademark Office. The USPTO has given the BOEBZI trademark a serial number of 86496011. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 16, 2018. This trademark is owned by Novartis AG. The BOEBZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, pharmaceutical preparations for treating skin diseases, pharmaceutical preparations for treating immune and autoimmune diseases
boebzi

General Information

Serial Number86496011
Word MarkBOEBZI
Filing DateTuesday, January 6, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 16, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, pharmaceutical preparations for treating skin diseases, pharmaceutical preparations for treating immune and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 15, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, July 16, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 16, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2017EXTENSION 5 GRANTED
Sunday, December 3, 2017EXTENSION 5 FILED
Sunday, December 3, 2017TEAS EXTENSION RECEIVED
Tuesday, May 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 21, 2017EXTENSION 4 GRANTED
Sunday, May 21, 2017EXTENSION 4 FILED
Sunday, May 21, 2017TEAS EXTENSION RECEIVED
Thursday, December 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 7, 2016EXTENSION 3 GRANTED
Friday, December 2, 2016EXTENSION 3 FILED
Friday, December 2, 2016TEAS EXTENSION RECEIVED
Wednesday, July 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2016EXTENSION 2 GRANTED
Tuesday, June 7, 2016EXTENSION 2 FILED
Monday, July 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 7, 2016TEAS EXTENSION RECEIVED
Wednesday, December 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2015EXTENSION 1 GRANTED
Monday, December 7, 2015EXTENSION 1 FILED
Monday, December 7, 2015TEAS EXTENSION RECEIVED
Tuesday, June 9, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 9, 2015ASSIGNED TO LIE
Tuesday, February 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 17, 2015ASSIGNED TO EXAMINER
Thursday, January 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 9, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

boebzi pharmaceutical preparations treating diseases autoimmune immune cancer prevention treatment skin